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Microfabricated thermoelectric controllers can be employed to investigate mechanisms underlying myosin-driven sliding of Ca2+-
regulated actin and disease-associated mutations in myoﬁlament proteins. Speciﬁcally, we examined actin ﬁlament sliding—
with or without human cardiac troponin (Tn) and α-tropomyosin (Tm)—propelled by rabbit skeletal heavy meromyosin, when
temperature was varied continuously over a wide range (∼20–63◦C). At the upper end of this temperature range, reversible
dysregulation of thin ﬁlaments occurred at pCa 9 and 5; actomyosin function was unaﬀected. Tn-Tm enhanced sliding speed
at pCa 5 and increased a transition temperature (Tt) between a high activation energy (Ea) but low temperature regime and a
low Ea but high temperature regime. This was modulated by factors that alter cross-bridge number and kinetics. Three familial
hypertrophiccardiomyopathy(FHC)mutations,cTnIR145G,cTnIK206Q,andcTnTR278C,causedysregulationattemperatures
∼5–8◦C lower; the latter two increased speed at pCa 5 at all temperatures.
1.Introduction
Biomolecular motors have clear promise for transport
applications in micro- and nanofabricated devices although
control of motion remains a major challenge [1–4]. Toward
that end, we constructed a microfabricated thermoelectric
controller for rapid and reversible actuation using myosin,
the biomolecular motor of muscle, and its partner ﬁla-
ment, actin [5, 6]. Thermal control of kinesin-microtubule
motility using thermally responsive polymers has also been
demonstrated as a possible temperature-dependent control
mechanism for biomolecular motors [7]. We present here
novel applications of our thermoelectric control system to
investigate changes in actin-myosin motility when Ca2+-
regulated thin (actin) ﬁlaments are used, and when thin-
ﬁlament Ca2+-regulatory protein mutations are introduced
that underlie an inherited cardiovascular disease, familial
hypertrophiccardiomyopathy(FHC)[8–10].Resultsprovide
insights into mechanisms of altered function when thin ﬁla-
ments are reconstituted with human cardiac Ca2+-regulatory
proteins troponin (Tn) and tropomyosin (Tm), and further
modulated by FHC-related mutations in cardiac Tn.
In the heart—and in vertebrate striated muscles in
general—contraction is physiologically controlled by bind-
ing of cytoplasmic Ca2+ to thin ﬁlaments. Thin ﬁlaments are
comprised of three major proteins: actin, Tm, and Tn that2 Journal of Biomedicine and Biotechnology
is itself a complex of three polypeptides [11]. Ca2+ activates
thin ﬁlaments by binding to Tn, leading to structural
changes that ultimately expose myosin-binding sites on actin
subunits [11]. Our previous work on the thermoelectric
controller utilized only myosin and unregulated F-actin, that
is, Ca2+-independent motility achieved using actin ﬁlaments
without Tn or Tm [5, 6]. This study was initiated because
Ca2+-regulated thin ﬁlaments could have several advantages
over unregulated F-actin in a thermoelectric nanoactuator.
First, Ca2+ would provide a secondary control mechanism
that is separate from temperature. An additional beneﬁt is
that the Ca2+-regulatory proteins Tn and Tm at saturating
Ca2+ can enhance function of the actomyosin system [12–
20]. These eﬀe c t so fT na n dT mo na c t o m y o s i nf u n c t i o n ,
however, appear to vary markedly over the limited temper-
ature ranges studied previously [16, 18, 21] and thus could
introduce nonlinearities to a thermoelectric nano-actuator.
Temperature has obvious physiological relevance as a
determinant of mammalian striated muscle contraction. It
aﬀects several fundamental aspects of muscle structure and
function [22–24] although temperature eﬀects on muscle
function appear to be greater at low temperatures used in
many experiments than at physiological temperature; exam-
ples are isometric tetanic tension [25–27] and maximum
mechanical power output [28]. Temperature also modulates
the control of striated muscle contraction by Ca2+ regulatory
proteins Tn and Tm, although there are both qualitative and
quantitativediscrepanciesonthispointinthestriatedmuscle
literature [22, 26, 29, 30]. Interestingly, mild hypothermia
has been reported to be a positive inotropic eﬀector in living
cardiac muscle due to interplay between temperature and
cardiac thin ﬁlament Ca2+ regulation [31]. Our thermo-
electric controller allows us to address these issues and
more in a single experiment through rapid exploration of
broad temperature regimes surrounding physiological tem-
perature.
Some mutations in Tn and Tm alter thin-ﬁlament
function in ways that might make the mutant proteins useful
in biomolecular motor-based transport applications. In
particular, mutations associated with familial hypertrophic
cardiomyopathy (FHC)—one of a growing number of dis-
easescausedbymutationsinthegenesforsarcomereproteins
including thin-ﬁlament Ca2+-regulatory proteins [8–10]—
may be especially useful in bionanomechanical systems
even though those mutations are devastating for patients
[32–41]. The molecular basis by which these mutations
alter thin-ﬁlament function and bring about cardiovascular
diseaseisunknown[8,10,42].Ourthermoelectriccontroller
could provide important insight into mechanisms by which
these mutations in myoﬁlament proteins alter contractile
function, and directly or indirectly signal changes in gene
expression that underlie the progression to pathological
cardiac hypertrophy in FHC.
2.MaterialsandMethods
2.1. Protein Preparations: Myosin, Heavy Meromyosin, Actin,
Troponin, and Tropomyosin. Florida State University’s Insti-
tutional Animal Care and Use Committee approved all
proceduresandprotocolsinvolvingvertebrateanimals.Adult
New Zealand White rabbits were housed in Florida State
University’s Laboratory Animal Resources facility and were
handled in accordance with the current National Institutes
of Health/National Research Council Guide for the Care and
Use of Laboratory Animals. Brieﬂy, rabbits were injected IM
with 3mg Acepromazine + 10mg/kg Xylazine + 50mg/kg
Ketamine. Following veriﬁcation of appropriate surgical
depth of anesthesia, the rabbits were exsanguinated via
laceration of the carotid artery. The euthanized animals were
skinned, eviscerated,andchilledonice.Backandlegmuscles
were removed for acetone powder, or back muscles only for
myosin preparation [12, 13, 43]. Myosin and the soluble
chymotryptic digest fragment heavy meromyosin (HMM)
were prepared from fast skeletal muscle as described [12,
13, 43, 44]. HMM was made from myosin stored <5w e e k s
in glycerol (1:1) at −20◦C; HMM was used within 3 days
after preparation. Rabbit muscle actin was puriﬁed from
muscle acetone powder as described [12, 13, 43, 45]. F-actin
was labeled with rhodamine phalloidin (RhPh; Molecular
Probes) for ﬂuorescence microscopy (Figure 1(a)). F-actin
(33μg/mL) and RhPh (1μM) were incubated in actin buﬀer
(AB) with 1mM DTT at 4◦C overnight; ﬂuorescently labeled
F-actin was stable at 4◦C for at least 2 weeks.
Recombinant human α-Tm was expressed in E. coli as a
homodimeric fusion protein with maltose binding protein
(MBP); α-Tm was puriﬁed following removal of the MBP
aﬃnity tag via thrombin cleavage [13, 33]. After removal of
the MBP tag, recombinant α-Tm has two extra amino acids
(GS-) at the N-terminus; GS- is a conservative alternative to
the AS-dipeptide in bacterially expressed Tm that substitutes
functionally for acetylation of Tm’s N-terminus [46, 47].
Puriﬁed Tn from human cardiac muscle (cTn) was obtained
from Research Diagnostics (Flanders, NJ), or coexpressed
recombinantly (rHcTn) in E. coli as a fusion protein with
glutathione S-transferase (GST); the ternary rHcTn complex
was puriﬁed following removal of the GST aﬃnity tag
via cleavage with TEV protease [13]. FHC mutations of
rHcTn were introduced via site-directed mutagenesis to
the bacterial coexpression plasmid; changes were veriﬁed
by DNA sequencing. Proteins were assessed by coomassie-
stained Tricine-SDS PAGE [48] and quantitative analysis
with a Kodak EDAS 290 digital imaging system.
2.2. In Vitro Motility Assays. The speed of RhPh F-actin
over HMM-coated surfaces was measured to assess the
kinetics of actomyosin interactions and, for reconstituted
thin ﬁlaments, their regulation by Ca2+. All aspects of the
motility experiments with unregulated F-actin, such as ﬂow
cell assembly, solution preparation, assay procedures, and
data collection were conducted as described [5, 13, 43,
49]. [HMM] applied to ﬂow cells was 250μgmL −1 in the
majority of assays to achieve high density of HMM (ρ)o n
the nitrocellulose-coated motility surface; to reduce ρ in a
limited set of experiments, 75μgmL −1 HMM was applied to
the ﬂow cell.
Thestandardmotilitybuﬀer(MB)contained10mMeth-
ylene glycol-bis(2-aminoethylether)-N,N,N ,N -tetraaceticJournal of Biomedicine and Biotechnology 3
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Figure 1: Temperature dependence of HMM-driven sliding of RhPh-labeled actin ﬁlaments determined using a microfabricated
thermoelectric heater. (a) Modiﬁed ﬂow cells were constructed as described [5]. Flow cells consisted of a microscope slide (light blue)
and a modiﬁed cover slip (gray and gold), separated by two, thin spacers and held together by nonﬂuorescent vacuum grease. Solutions
(Section 2.2) are pipetted through the ﬂow cell as indicated by the blue, dashed arrows. To warm the ﬂow cell, current is injected via circuit
ε1 into a microfabricated thermoelectric heater (gold) on the coverslip’s outer surface; ﬂow cells are cooled by circulating chilled water
through a copper coil wrapped around the microscope objective. Temperature is monitored via a linear, resistive thermometer (dark gold
structure)thatwasmicrofabricatedontheinnerfaceofthecoverslip(i.e.,onthesamesidewhereactomyosinmotilityoccurred,andopposite
to the side with the thermoelectric heater); temperature is obtained from a calibrated voltage readout (V) with bias current set by circuit ε2.
Motion of ﬂuorescently labeled ﬁlaments on the inner side of the coverslip (top micrograph) is observed and recorded through a window
(black, dashed arrow) located immediately adjacent to the thermometer. (b) Time course of temperature (gray line; right ordinate) and
sliding speed (solid symbols; left ordinate) for regulated thin ﬁlaments (F-actin plus native cTn and α-Tm) at pCa 5 during the heating phase
of three cycles of heating and cooling (Section 2). Points represent mean ± S.D. of the sliding speed for 3–8 ﬁlaments during 1 s. Note that
the upper limit of the temperature-dependent increase in sliding speed occurs at ∼54◦C( t>4.5 min). (c) The data from (b) were replotted
to eliminate time: cycle 1 (), cycle 2 (), and cycle 3 (). An additional dataset for unregulated F-actin sliding is shown: cycle 1 ( )a n d
cycle 2 (). Note that the sliding speed of regulated thin ﬁlaments at the highest temperature is almost the same as for unregulated F-actin.
acid (EGTA), 20mM 3-(N-Morpholino)propanesulfonic
acid (MOPS), [K+] = 50mM, [Na+] = 15mM, pMg 3
(pMg =− log10[Mg2+], where [Mg2+] is in molar units),
and appropriate amounts of Tris+, and acetate (anion) to
obtain an ionic strength of 0.085M at pH 7. Concentrations
of Ca2+,M g 2+,N a +,K + were determined taking into account
known metal ion binding constants and their enthalpies
[32, 50]; solution composition was chosen to minimize
enthalpic changes in pH in ﬂow cells when temperature
was varied. Glucose (3mg/mL), 0.1mg/mL glucose oxidase,
0.018mg/mL catalase (Boeringher-Mannheim), and 40mM
dithiothreitol (DTT) were added immediately prior to an
assay to minimize photooxidation and photobleaching [49].
Experiments were conducted at saturating [Ca2+]( p C a5 ,
where pCa =− log10[Ca2+], with [Ca2+] in molar units) or,
where indicated, at low [Ca2+] (pCa 9); note that [Ca2+]
does not aﬀect sliding speed of unregulated F-actin [12, 14].
Methylcellulose (ﬁnal concentration 0.3%), dialyzed against
sodium azide (0.02%), was added to MB to prevent actin
ﬁlament diﬀusion away from the assay surface [12, 49, 51].
Solutions for assays with reconstituted thin ﬁlaments were
the same as for unregulated F-actin, except for the last two
solutions: the buﬀer applied to the ﬂow cell before MB
contained 75nM each of α-Tm and either native cTn or
recombinant hcTn and was incubated for three minutes
before infusing MB containing the same concentrations of
Tn and Tm [12, 13, 32, 50]. The minimum concentrations
of native or WT Tn and Tm added to MB to obtain well-
regulated ﬁlaments at 30◦C were determined by titrations
and applying the following criteria: ﬁlament sliding was4 Journal of Biomedicine and Biotechnology
Table 1: Metabolite concentrations in standard and modiﬁed motility buﬀers.
Metabolites Standard1 Modiﬁed solutions for motility assays2
Motility buﬀer Control High Pi Low ATP
[ATP] 2mM 2mM 2mM 0.2mM
Sucrose phosphorylase — 5.3μg/mL — 5.3μg/mL
Sucrose — 10mM 10mM 10mM
[Pi] ∼10μM ∼1μM4 m M ∼1μM
Creatine kinase (CK) — 0.1mg/mL 0.1mg/mL 0.1mg/mL
Creatine (Cr) — 30μM3 0 μM1 2 μM
Creatine phosphate (CP) — 1mM 1mM 1mM
[ADP] ∼10μM 0.42–0.57μM 0.42–0.57μM ∼0.02μM
Values for [ATP], [Pi], and [ADP] represent ﬁnal concentrations in motility buﬀers. [Pi] in columns 3 and 5 were estimated using Keq = 0.06 for the reaction
sucrose + Pi ↔ α-D-glucose-1-phosphate + D-fructose [52, 54]. [ADP] estimates are based on the equilibrium constant (Keq) for the reaction ATP + Cr
↔ ADP + CP, and are given in columns 3-4 with lowest and highest value corresponding to the lowest (27◦C) and highest (42◦C) temperatures employed,
r e s p e c t i v e l y .T h ee s t i m a t eo f[ A D P ]i nc o l u m n2w a sb a s e do nC h a s ea n dK u s h m e r i c k[ 53].
1Motility buﬀer (MB) employed in the majority of experiments (data in Figures 1–4) did not include sucrose phosphorylase and creatine kinase.
2Modiﬁed motility buﬀers were used for experiments shown in Figure 5.
inhibited at pCa 9, while motility was fast and uniform at
pCa 5 and standard temperature of 30◦C[ 12, 13, 32, 50].
In a limited set of motility experiments, standard MB
was modiﬁed to vary metabolite concentrations (Table 1)
as follows: either 5.3μgmL −1 sucrose phosphorylase and
10mM sucrose were added to reduce inorganic phosphate
(Pi) [52] or acetate was partially replaced by Pi to achieve the
high Pi condition (sucrose phosphorylase was not added);
contaminating ADP was reduced to <1μM by addition of
creatine phosphate (CP) and creatine phosphokinase (CK)
[53].
Motility data were collected while varying temperature
byemploying modiﬁed ﬂow cellscontaining microfabricated
Au heater and thermometer elements (Figure 1(a)), where
the thermometer is located immediately adjacent to the
viewing region [5]. In experiments using the thermoelectric
heater, cooling was achieved by circulating chilled water
through a copper coil wrapped around the microscope
objective; in a limited set of experiments, assays at con-
stant temperature were achieved by circulating temperature-
controlled water through the coil surrounding the objective
[13, 43]. Motility speed was analyzed using MetaMorph soft-
ware (Universal Imaging) as described [5]. Stacks of frames
(one stack for each second of temperature transient data, or
10–12 stacks for each constant temperature experiment from
one ﬂow cell) were created from digitized movies.
2.3. Statistical Analyses. Averages and error estimates were
calculated with Microsoft Excel 2000. Averages are given as
unweighted mean ± SD. Linear regression analyses were per-
formed using Microsoft Excel 2000 or SigmaPlot (Windows
versions 8.0 and 11.2; SPSS Inc., Chicago, IL); nonlinear
regression analyses were performed using SigmaPlot.
A transition temperature (Tt)w a se s t i m a t e df r o m
Arrhenius transformed speed versus temperature data that
exhibited a change in slope with temperature. To obtain
Tt, the data were divided into two parts (high- and low-
temperature regimes) that were separated by two adjacent
points on the Arrhenius plot’s temperature axis; several such
divisions of each dataset were processed using the following
algorithm. Linear regressions were obtained for each regime,
and the intersection point determined for those regressions.
In general, the intersection point does not fall between the
two data points that separate the high and low temperature
regimes. The small number of intersection points that did
fall between the high- and low-temperature regimes were
considered to be candidates for Tt; in the few instances when
there was more than one candidate point, the median value
was chosen for Tt.
3. Results
3.1.TemperatureDependenceofUnregulated F-ActinandReg-
ulated Thin-Filament Sliding. To examine sliding of Ca2+-
regulated thin ﬁlaments over a broad range of temperatures,
we employed a thermoelectric controller (Figure 1(a)) that
enables both rapid and continuous variation of a ﬂow cell’s
temperature [5]. Figure 1(b) shows sliding speed (solid sym-
bols) as a function of time for thin ﬁlaments reconstituted
with native cTn·α-Tm at pCa 5 during three heating phases
of cyclic heating and cooling (∼20–60◦C). Note that the
peaktemperature(grayline)increasedwitheachcycle.Speed
increased with temperature during the heating phase of each
cycle over most of the range examined. As temperature
increased during the third cycle, however, sliding speed of
regulated actin reached a maximum at ∼54◦C, and then
speed declined above ∼58◦C( Figure 1(b)). This anomalous
decline in speed for regulated thin ﬁlaments is particularly
evident in Figure 1(c), solid symbols where data from all
three heating cycles of Figure 1(b) were combined to show
the temperature dependence of sliding speed. Superposition
of the data from three cycles suggests that brief exposure to
elevatedtemperatureoveratleasttheﬁrsttwocycleswasfully
reversible.
Comparison ofregulatedversusunregulatedF-actinslid-
ing speed at high temperature suggests that the anomalous
decline for regulated thin-ﬁlament speed is more likely
due to an eﬀect of temperature on Tn·Tm rather than onJournal of Biomedicine and Biotechnology 5
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Figure 2: Thin ﬁlaments remain motile but lose Ca2+-regulation at high temperature. (a) Time course of temperature (gray line; right
ordinate) and sliding speed (solid squares, red ﬁll; left ordinate) for regulated thin ﬁlaments (F-actin plus rhcTn and α-Tm) at pCa 9 during
theheatingphaseofﬁvecyclesofheatingandcooling.Pointsrepresentthemeanslidingspeedfor3–5ﬁlamentsduring1s.AtpCa9,nonzero
slidingspeedsinheatingcycles3–5indicatelossofCa2+-regulation(dysregulation);notethattemperature-dependentlossofCa2+-regulation
is fully reversible following cooling (beginning of cycles 4-5). (b) Data from (a) (pCa 9; solid squares, red ﬁll) were replotted to eliminate
time. Additional data for regulated thin ﬁlaments (F-actin plus rhcTn and α-Tm) at pCa 5 () and unregulated F-actin ( )f r o mt h es a m e
series of experiments are also shown for comparison.
actin or HMM. Regulated ﬁlament speed at pCa 5 (solid
symbols) was at least as fast as that for unregulated F-
actin (open symbols) at each temperature over the range
examined (∼20–60◦C) (Figure 1(c)), consistent with previ-
ous reports over more limited temperature ranges [12, 13,
16,20].ThespeedofunregulatedF-actin,however,increased
continuously over the entire temperature range—even at
the highest temperatures examined, where regulated thin-
ﬁlament speed declined. To test the hypothesis that Tn·Tm
is responsible for the anomalous decline in speed (Figure 1),
we examined the eﬀect of temperature on regulated thin-
ﬁlamentmotilityatpCa9,thatis,intheabsenceofactivating
Ca2+. Figure 2(a) shows sliding speed (red symbols) as
a function of time for thin ﬁlaments reconstituted with
rHcTn·α-Tm at pCa 9 during ﬁve heating phases of cyclic
heating and cooling. Note that the peak temperature (gray
line) increased with each cycle, as in Figure 1(b). Data
from all ﬁve heating cycles of Figure 2(a) were combined
to show the temperature dependence of sliding speed in
Figure 2(b). As expected in the absence of Ca2+, regulated
thin ﬁlaments exhibited little or no motion (note red
symbols at speed ∼0 )o v e rab r o a dr a n g eo ft e m p e r a t u r e s
(∼20–43◦C). Above ∼43◦C, ﬁlament sliding was observed
indicating loss of Ca2+ regulation (red symbols; Figure 2)
although the average speed was generally less than or similar
to that of unregulated F-actin (open symbols; Figure 2(b)).
As for native cTn (Figure 1(c), solid symbols), rHcTn WT
regulatedthinﬁlamentsatpCa5(Figure 2(b),solidsymbols)
were faster than unregulated F-actin (Figure 2(b),o p e n
symbols); an anomalous decline in speed with WT rHcTn
(Figure 2(b), solid black circles) occurred at slightly a higher
temperature (by ∼4–5◦C) than for native cTn (Figure 1(c),
solid symbols), suggesting increased stability of the re-
combinantly expressed protein or its interactions with
F-actin-α- T m .T h ea p p a r e n tl o s so fC a 2+-regulation, indi-
cated in Figure 2 by thin ﬁlament sliding (nonzero speeds) at
pCa9fortemperaturesabove ∼43◦C,iscompletelyreversible
because thin-ﬁlaments stopped moving after temperature
was lowered during the cooling phase of each cycle at pCa
9( Figure 2(a)).
Arrhenius analysis of the data in Figure 1(c) reveals that
the activation energy (Ea) for regulated thin-ﬁlament speed
at pCa 5 exhibited two distinct values, with a change in the
slope at Tt ∼ 38◦C( Figure 3, solid symbols and black solid
lines). For regulated thin ﬁlaments (Figure 3, solid symbols
andblacksolidlines),Ea attemperaturesbelowphysiological
(100.4kJ/mol) was >2-fold greater than Ea for the higher-
temperature regime (41.8kJ/mol), while the latter value was
closer to that of unregulated F-actin (61.9kJ/mol) (Figure 3,
open symbols and black dashed line). Temperature has a
dramatic, nonlinear eﬀect on the viscosity of water [55], and
the speed of ﬁlament sliding varies inversely with solvent
viscosity [43, 56]; we therefore asked whether temperature-
dependent changes in solvent viscosity could explain the
nonlinear Arrhenius relation (Figure 3). The data in Figure 3
were processed to remove the temperature dependence of
solvent viscosity by ﬁrst normalizing viscosity with respect
to that of water at 37◦C( i . e . ,b o d yt e m p e r a t u r e ) ,a n ds e c o n d
assuming that speed varies inversely with solvent viscosity
[43, 56]. After removing the eﬀects of viscosity, slopes of
the Arrhenius plots were reduced (Figure 3, blue lines).
Ea for unregulated F-actin decreased from 61.9kJmol−1
to 47.0kJmol−1 (Figure 3, blue dashed line). For regulated
thin ﬁlaments, Ea decreased from 100.4 to 83.9kJmol−1 for
T<38◦C, and from 41.8 to 26.6kJmol−1 for T>38◦C
(Figure 3, black versus blue solid lines). The latter value
of Ea is suggestive of a diﬀusion-limited process, in accord
with the previously observed inverse relationship between6 Journal of Biomedicine and Biotechnology
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slope at ∼38◦C( Tt) for regulated thin ﬁlaments. Eﬀects of temperature-dependent changes in solvent viscosity (normalized to that at body
temperature, 37◦C) were removed by assuming that speed varies inversely with viscosity, as demonstrated experimentally [43]; the net result
of this correction in all instances is a decrease in apparent Ea.
speed and viscosity [43, 56]. Despite the reduction of
slopes for regulated thin-ﬁlaments, the ratio of Ea’s between
the two temperature regimes increased from 2.4 to 3.1.
Below 38◦C, the ratio of Ea’s for regulated thin-ﬁlament
sliding speed with respect to that of unregulated F-actin
increased from 1.6 to 1.8. It is clear from this analysis
that it is important to consider temperature-dependent
changes in solvent viscosity when evaluating actin ﬁlament
slidingspeed.NonlinearitiesintheArrheniusplot(Figure 3),
however, cannot be explained by temperature-dependent
changes in solvent viscosity.
3.2. Inﬂuence of FHC Mutations in Troponin on the Tem-
perature Dependence of Thin-Filament Sliding. Because the
temperaturedependenceofmaximumﬁlamentslidingspeed
isinﬂuencedbythepresenceandfunctionofTn·Tm(Figures
1–3), and FHC-related mutations in troponin profoundly
inﬂuence the Ca2+ dependence of myoﬁlament function [8–
10, 57], we utilized the thermoelectric controller to investi-
gate temperature eﬀects on thin ﬁlaments reconstituted with
rHcTn·α-Tm when one of three FHC-related mutations—
TnI R145G, TnI K206Q, or TnT R278C—was incorporated
into the troponin complex (Section 2). At pCa 5, ﬁlament
sliding speed for two mutants (TnI K206Q and TnT R278C)
wasfasterthanWTovertherangeoftemperaturesexamined,
consistent with previously reported data for TnI K206Q
using recombinant rat cardiac Tn [32]. In contrast, speed
with TnI R145G was similar to WT (Figure 4).
The micromechanical thermal assays with thin ﬁlaments
containing FHC mutations in rHcTn suggest that either
the mutant troponins are intrinsically less thermally stable,
or the regulatory interaction of mutant troponin with
F-actin-α-Tm is less stable, or both (Figure 4(a)). All three
of the FHC mutants exhibited anomalous declines in speed
at lower temperatures than WT rHcTn, with the cTnT
R278C and cTnI R145G mutations resulting in ∼4-5◦C
decreases, and the cTnI K206Q mutation leading to a larger,
∼8-9◦C decrease in the temperature at which the anomalous
decline in speed occurred as temperature continued to rise
(Figure 4(a)).
Arhennius analysis suggests that there was little eﬀect of
the FHC mutations on Tt for thin ﬁlaments reconstituted
with WT or mutant rHcTn, with values of 38–41◦Cw h e r e
theycouldbeunambiguouslydetermined(Figure 4(b)).This
was similar to the value of Tt = ∼38◦C obtained with
native cTn (Figure 3). The slopes of the high- and low-
temperature regimes were more similar for the two fastest
mutants (cTnT R278C and cTnI K206Q) compared with
WT or the cTnI R145G mutant (Figure 4(b)); in fact, it was
not possible to unambiguously identify a value of Tt from
data with TnI K206Q by the algorithm used (Section 2).
When the data for unregulated F-actin from Figure 2(b)
(opensymbols)wereplottedinArrheniusform(Figure 4(b),
gray dashed lines), a value of Tt ∼ 33◦C was obtained
in contrast to the dataset in Figures 1 and 3,w h e r eTt
for unregulated F-actin could not be determined because
there were not suﬃcient points below Tt to deﬁne a low-
temperature regime.
3.3. Inﬂuence of Factors that Aﬀect Cross-Bridge Number
and Kinetics on Temperature Dependence of Unregulated
F-Actin and Regulated Thin-Filament Sliding Speed. To
address whether changes in the number of cross-bridges and
distribution of cross-bridge states could be responsible for
diﬀerences in sliding speed and Ea between unregulated F-
actin and regulated thin ﬁlaments at saturating Ca2+,w e
studied the eﬀects of altered HMM density, and metabolite
concentrations which are known to aﬀect the fraction ofJournal of Biomedicine and Biotechnology 7
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Figure 4: Inﬂuence of FHC-linked mutations in human cardiac troponin on temperature dependence of thin-ﬁlament sliding at pCa 5.
Thin ﬁlaments were reconstituted with α-Tm and either rhcTn WT (circles, black), rhcTn TnI,R145G (triangles, green), rhcTn TnI,K206Q
(squares, yellow), or rhcTn TnT, R278C (diamonds, blue). Data were obtained during the heating phases of multiple heating/cooling cycles,
as in Figure 1; note that WT data were replotted from Figure 2(b). (a) Points represent the mean sliding speed for 3–8 ﬁlaments during 1s.
Note that speeds with TnI mutant K206Q [32] and TnT mutant R278C were generally elevated over WT. (b) Arrhenius analysis of data
from (a). Symbols and colors as in (a); unregulated F-actin from the same series of experiments (Figure 2(b)) was also included in (b)
(inverted triangle and dashed lines; light gray). Each dataset was ﬁt by two linear regressions after omitting data above ∼60◦C( W T ) ,∼54◦C
(cTnI R145G), ∼51.5◦C (cTnI K206Q), or ∼55◦C (cTnT R278C). Regression lines are shown without correction for temperature-dependent
changes in solvent viscosity; points correspond to Tt, the intersection of each pair of lines. Filament sliding speeds are expressed in μms −1.
weakly versus strongly bound cross-bridges. Solutions were
modiﬁed in the following ways, and compared with a control
condition that was itself modiﬁed in comparison with assays
reported in Figures 1–4 (Section 2): decreased [ATP] from
2mM (Control) to 200μM, increased [Pi] from ∼1μM
(Control) to 4mM, or reduced HMM density (ρ)f r o m
0.25mg/mL (Control) to 0.075mg/mL (Figure 5). In these
experiments only, motility assays were performed at steady-
state temperatures of 27, 32, 37, or 42◦C so that we could
calculatemetaboliteconcentrationsinthepresenceofCP/CK
to buﬀer ATP/ADP and reduce ADP (Section 2), conditions
that did not apply to the nonsteady state temperature assays
reported in Figures 1–4.
Sliding speed increased with temperature for each
condition tested for both regulated thin ﬁlaments at pCa
5 and unregulated F-actin (Figure 5) as expected for the
temperature range examined. Sliding speed with respect
to the Control condition was reduced signiﬁcantly for
the low ATP condition at the two highest temperatures
for unregulated F-actin (Figure 5(a)) and at the three
highest temperature points for regulated thin ﬁlaments
(Figure 5(b)). Sliding speed at high Pi (Figure 5)w a sh i g h e r
than in Control conditions at the two lower temperatures
for both regulated thin ﬁlaments and unregulated F-actin.
Decreasing ρ had little eﬀect on unregulated F-actin sliding
speed (Figure 5(a)) but decreased regulated thin-ﬁlament
speed signiﬁcantly at the three lowest temperatures (27, 32,
and 37◦C, Figure 5(b)). Addition of Tn·Tm was typically
associated with increased speed, but not at low ATP, which
is in good agreement with the results of Homsher et al. [16].
At reduced ρ, the enhancing eﬀect of Tn·Tm was greater
at higher temperatures. The fraction of motile ﬁlaments at
reduced ρ increased over the three lowest temperatures (27,
32, and 37◦C) for unregulated F-actin (inset, Figure 5(a)),
but over the entire temperature range for regulated thin
ﬁlaments (inset Figure 5(b)).
4. Discussion
In this study, we utilized microfabricated thermoelectric
devices to rapidly and reversibly investigate the inﬂu-
ence of temperature on myosin-driven sliding of Ca2+-
regulated, muscle thin ﬁlaments over a wide temperature
range (∼20–60◦C). To investigate molecular mechanisms of
normal cardiac function and pathophysiology, thin ﬁlaments
were reconstituted with human cardiac Tn and Tm, or
with FHC-related mutants of human cardiac Tn. The major
results of this study are as follows.
(a) At pCa 5, sliding speed of regulated thin ﬁlaments
increased reversibly with increasing temperature
(∼20–∼54◦C) as expected and was faster than unreg-
ulated F-actin over that range.
(b) Reversible dysregulation—loss of Ca2+-regulation—
occurred at both pCa 5 and pCa 9 at the upper
end of the temperature range examined; this suggests
thermal unfolding of the cardiac regulatory proteins
and/or their dissociation from actin.8 Journal of Biomedicine and Biotechnology
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Figure 5: Inﬂuence of motility conditions on temperature dependence of ﬁlament sliding speeds for (a) unregulated F-actin and (b)
regulated thin ﬁlaments (F-actin plus native cTn and α-Tm) at pCa 5. Points are the mean of means ± S.D. from 45–75 ﬁlaments in each of
≥3 individual ﬂow cells and are plotted against steady-state temperature (27– 42◦C) for four conditions. For this series of experiments only,
control conditions (circles, solid lines) were [Pi] = ∼1μM (achieved by removal of contaminating Pi; Section 2); [ATP] = 2mM(buﬀered
by CP and CK; Section 2), and high ρ achieved by infusing 0.25mg/mL [HMM] into the ﬂow cell. Conditions were modiﬁed to test low
ATP (200μM ATP; inverted triangles, short dashed lines); high Pi (4mM Pi; squares, long dash dotted lines); or low ρ (0.075mg/mL HMM;
triangles, dash dotted line). Lines were drawn to connect the points. Insets: temperature dependence of fraction of ﬁlaments moving under
low ρ condition plotted for (a) unregulated F-actin and (b) regulated thin ﬁlaments at pCa 5. Note that the fraction of regulated thin
ﬁlaments, but not unregulated F-actin, increases continuously over this temperature range.
(c) Arrheniusanalysisindicatestwotemperatureregimes
withdiﬀerent Ea; the transition temperature between
those regimes was higher for regulated thin ﬁlaments
than unregulated F-actin, and this is explained by a
simple model.
(d) Factorsthataltercross-bridgenumberandkinetics—
[ATP], [Pi], and ρHMM—alter the temperature de-
pendence of sliding speed of both regulated thin
ﬁlaments and unregulated F-actin in qualitatively
similar ways that provide insight into rate limiting
factors.
(e) Three FHC mutants in cTn (cTnI R145G, cTnI
K206Q, and cTnT R278C) destabilize regulatory
protein structure and/or interactions with F-actin-
Tm and may also alter the kinetics of thin ﬁlament
sliding at pCa 5.
4.1. Functional Assays for Thermal Stability of Regulated
Thin Filaments and Ca2+-Regulatory Proteins. Ac u s t o m
thermoelectric controller [5] that was used in this study
(Figure 1(a)), and miniaturized versions thereof [6], provide
a novel approach to evaluate contractile protein function
over a wide range of temperatures and multiple temperature
cycles. The multiple datasets collected this way with native
and WT regulatory proteins (Figures 1–3) complement and
expand the range of information that can be obtained using
conventional motility assays [16, 58, 59] and traditional
approaches to studying protein structure in solution [60–
63]. Our device provides a simpler readout of temperature
than relying on intensity of the ﬂuorescent label [64].
Speed of unregulated F-actin increased monotonically over
the temperature range used (Figures 1-2, open symbols),
indicating that HMM and actin are not aﬀected detrimen-
tally at temperatures below 60◦C; this is consistent with
previous functional measurements [5, 64]a n ds t r u c t u r a l
assays showing that the structure of Ph-stabilized F-actin in
solution is thermally stable up to 78◦C[ 62], while unfolding
of subfragment 1 (S1) was reported for temperatures greater
than 58◦C in the presence of analogs of ATP or ADP·Pi [63].
Dysregulation of thin ﬁlaments at elevated temperatures
was observed at both pCa 5 (Figures 1-2) and pCa 9
(Figure 2), suggesting that altered function was likely due
to dissociation of Tn·Tm from actin or denaturation of
Tn and/or Tm. At pCa 5, the anomalous decline in sliding
speed for regulated thin ﬁlaments above ∼54◦C suggests a
loss of regulation (dysregulation) because as temperature
increased, speed decreased toward that of unregulated F-
actin (Figure 1(c)). At pCa 9, ﬁlament sliding was observed
at temperatures above ∼43◦C; speed increased with temper-
ature and was generally lower than, but approached that of
unregulated F-actin (Figure 2), indicating that cTn stabilizes
actin·Tm at pCa 5. Taken together, these results from
microthermal heater assays provide functional correlates
that are consistent with previous solution studies showing
half-maximal dissociation of Tm from Ph-stabilized F-
actin·Tm complex (no Tn) at 46–48◦C, and unfolding of
Tm alone in solution that was resolved into two separate
calorimetric domains with maxima of 42 and 51◦C[ 61, 62].
More generally, our results demonstrate that microthermalJournal of Biomedicine and Biotechnology 9
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Figure 6: Temperature dependence of two apparent rate constants that may limit actin ﬁlament sliding speed at pCa 5. Data in Figure 3 (T<
∼54◦C) for sliding speed of regulated thin ﬁlaments were ﬁtted to (2). The inverse of each of the exponential rate terms in the denominator
of (2) is plotted: for WT regulated thin ﬁlaments, one rate exhibits only slight temperature sensitivity (solid black line) while the other is
markedly temperature sensitive (red line). The rate-limiting step for ﬁlament sliding is the smaller of the two rates, and Tt is the intersection
of the two lines. The less temperature sensitive rate is also shown for unregulated F-actin (dashed black line; data from Figure 3). Note that
by assuming the temperature-sensitive rate (red line) is similar for both instances, decreasing the less temperature sensitive rate (black arrow,
as observed experimentally with unregulated F-actin) decreases Tt.
heater assays can provide unique, molecular level insights
into muscle thin-ﬁlament function, particularly when the
maximum temperature is limited such that the eﬀects
of temperature on Ca2+ regulation are fully reversible
(Figure 2(a)).
4.2. Temperature Dependence of Ca2+-Regulated Thin-
Filament Sliding at pCa 5. Comparison of temperature-
dependence of regulated thin-ﬁlament sliding at pCa 5 with
that of unregulated F-actin provides insights into the roles
of cardiac troponin and tropomyosin. This is important in
light of the observation that not only do Tn-Tm modulate
the thin ﬁlament side of actomyosin interactions but cTn
can also directly accelerate myosin ATPase activity even in
the absence of actin and Tm [20]. This direct eﬀect of cTn
on myosin kinetics is presumed to at least partially underlie
Tn·Tm’s enhancement of maximum unloaded sliding speed
under a wide variety of conditions (e.g., Figures 1(c), 2(b),
3, 4(b),a n d5), although it is also possible that there are
diﬀerences in the myosin binding interface due to Tm·S1
interactions [65] or regulatory protein-induced structural
changes in actin itself [15].
While it is clear that Tn·Tm modulate ﬁlament sliding
speed primarily by aﬀecting the number of cross-bridges
at submaximal Ca2+ activation [12, 14, 50], the most
straightforward mechanism by which Tn·Tm could directly
enhance actomyosin kinetics at saturating Ca2+ is through a
reductioninthetimethatcross-bridgesspendinthestrongly
bound state (ts) under the unloaded conditions of a motility
assay,asobservedexperimentally[33].Themaximumsliding
speed (sm) for regulated thin ﬁlaments at saturating Ca2+ or
for unregulated F-actin is simply related to myosin step size
(dx)a n dts as proposed by Uyeda et al. [51]:
sm =
dx
ts
. (1)
To accommodate the observed, biphasic Arrhenius plots
(Figures 3 and 4(b)), we assume that dx = 0.0055μm[ 66]
for all conditions examined and rewrite (1)t oe x p r e s sts as
the sum of two exponential terms:
sm =
0.0055
(ae−bT +ce−dT)
,( 2 )
which, when ﬁt to the data for regulated thin ﬁla-
ments in Figure 3, yields sm = 0.0055/(0.301e−0.1855T +
0.00145e−0.0277T)w i t hR2 = 0.97. Separating the two terms
and plotting them as rates, we can see that one varies
little with temperature (black solid line; Figure 6) and while
the other is highly temperature sensitive (red solid line;
Figure 6). Assuming that the more highly temperature-
dependent term is similar for both regulated thin ﬁlaments
and unregulated F-actin, regression estimates were obtained
for unregulated F-actin sliding in Figure 3, c = 0.0225
and d = 0.0676 (R2 = 0.97), and the corresponding rate
prediction was plotted in Figure 6 (black dashed line).
If the intersections of the red line with the two black lines
in Figure 6 are related to discontinuities in the Arrhenius
plots (Figures 3 and 4(b))a n dt h u sv a l u e so fTt, then the
simple analysis of (1), (2)i si na c c o r dw i t ho b s e r v a t i o n s
that the transition from high to low Ea will occur at higher
temperature for regulated thin ﬁlaments (red and solid black
lines) than for unregulated F-actin (red and dashed black
lines). In this model, the rate limitation for ﬁlament sliding
at a given temperature would be the lower of the two rates
from the red line and one black line: at low temperatures,
the steeper, red value is limiting, while the shallower, black
valueislimitedatelevatedtemperatures(Figure 6).Thetem-
perature dependence of unloaded ﬁlament sliding speed has
been reported to vary as a function of temperature in some
but not all conditions [16, 58, 59]. For unregulated F-actin,
Arrhenius plots have been previously reported to be linear
within 20–60◦C[ 5] and 7–25◦C[ 16], but nonlinear within
3–42◦C with a transition temperature (Tt) of 15.4◦C[ 59],10 Journal of Biomedicine and Biotechnology
and 10–35◦Cw i t haTt ∼ 25◦C[ 58, 67]. Tt depends not
only on the experimental conditions but also on whether
Ca2+-regulatory proteins are present. The Arrhenius plot
of ﬁsh myoﬁbrillar ATPase at saturating Ca2+ exhibited a
discontinuity [68], while this was not the case for in vitro
motility sliding speed and actin-activated MgATPase activity
with ﬁsh myosin and unregulated F-actin [69]. For regulated
thin ﬁlaments, Homsher et al. [16] reported a break in the
Arrhenius plot around 12.5◦C that was not observed for
unregulated F-actin within the 7–25◦C temperature range.
In this study using micromechanical thermal assays, dis-
continuities in Arrhenius plots for regulated thin ﬁlaments
(Figures 3 and 4(b)) occurred at a higher temperature
than when Tt could be identiﬁed for unregulated F-actin
(Figure 4(b)). While there is no universal agreement in the
limited data available on absolute values for Tt for ﬁlament
sliding, there does appear to be general agreement that
Tn·Tm modulates the temperature dependence of unloaded
ﬁlament sliding. Our data suggest that this modulation of
Tt by human cardiac Tn·Tm occurs around physiological
temperature.
The existence of discontinuities in Arrhenius plots
suggests that diﬀerent factors are rate-limiting to ﬁlament
sliding above and below Tt. What factors could contribute
to this diﬀerence? Prior experiments with regulated thin
ﬁlaments at subsaturating levels of Ca2+ suggested that the
number of cross-bridges is limiting to sliding speed at 30◦C
[12, 50]. The data in Figure 5 indicate that sliding speed
is markedly sensitive to a reduction in the density (ρ)o f
HMM on the ﬂow cell surface at 27 and 32◦Cf o rb o t h
unregulated F-actin and especially regulated thin ﬁlaments
at maximal Ca2+ activation. At higher temperatures (37 and
42◦C), however, there was little or no eﬀect of the same
reduction in ρ on sliding speed for either unregulated F-
actin or regulated thin ﬁlaments (Figure 5). In addition,
the fraction of moving ﬁlaments at low ρ increased with
temperature for regulated thin ﬁlaments at pCa 5 over
the entire temperature range (Figure 5(b), inset), while for
unregulated F-actin, the fraction started at a lower value
and plateaued (Figure 5(a), inset). Taken together, these
observations suggest an increase in strong cross-bridges with
temperature for both unregulated F-actin and regulated thin
ﬁlaments, consistent with previous reports using in vitro
assays and permeabilized muscle ﬁbers [70–72]. Thus, it
appears that Tn·Tm can modulate at least one rate-limiting
factor, and also Tt, around physiological temperature: once a
temperature (Tt)isattainedatwhichtheavailabilityofcross-
bridges is great enough to guarantee continuous ﬁlament
sliding, further increase of speed with temperature will only
depend on less temperature-sensitive kinetic rates that are
associated with transitions between strongly bound cross-
bridge states, and will therefore be characterized by low Ea
(Figure 6, cross-over from red to black lines).
In addition to the number of cross-bridges, ﬁlament
sliding speed can be altered by variations in the substrate
and products of the ATPase reaction through modulation
of actomyosin kinetics. According to the model implicit in
(1), changes in metabolite concentration would primarily
inﬂuence ts, and therefore sm, and also the number of
attached cross-bridges. For example, Tn·Tm could aﬀect
the kinetics of ATP-induced cross-bridge dissociation that
has been suggested to limit ﬁlament sliding speed, at least
in fast skeletal muscle at low temperature [16, 73]. When
[ATP] was reduced to 200μM—a substrate concentration
that is similar to the apparent Kd for sarcomere shortening
velocity and ﬁlament sliding speed [16, 53, 74, 75]—
inhibition of speed was greater for regulated thin ﬁlaments
at pCa 5 than unregulated F-actin (Figure 5), as reported
by Homsher et al. [16]. Inhibition of sm at low ATP levels
is explained by slower ATP-induced detachment of cross-
bridgesattheendofattachedphasethecycle,whichincreases
ts (1); the fraction of strongly attached cross-bridges would
also increase, although the dominant factor in determining
sm in this instance is slower cross-bridge cycling. The
relativelygreaterinhibition ofregulatedthin-ﬁlamentsliding
was accentuated at higher, more physiological temperatures
(Figure 5). The net result was a generally shallow slope of
speed versus temperature for both regulated thin ﬁlaments
and unregulated F-actin (Figure 5) that corresponds to a
regime of relatively low Ea. The expectation would then be
that reduced [ATP] should shift Tt to a lower temperature
(Figure 6) although it was not resolved in this experiment,
likely because of the lower limit of temperature examined.
There are some interesting parallels with reduced [ATP]
eﬀects, along with signiﬁcant diﬀerences, when the con-
centration of product Pi was increased from micromolar
levels to 4mM (Table 1), that is, the highest concentration
that we could achieve without necessitating an increase in
ionic strength. Temperature has previously been shown to
modulate the eﬀe c to fP io ni s o m e t r i cf o r c ei nm u s c l e
ﬁbers, although there is disagreement about whether Pi is
either more [29, 76]o rl e s s[ 77] inhibitory of isometric
force as temperature increases. While Pi inhibits isometric
force, elevated Pi increases sliding speed for both regulated
thin ﬁlaments at pCa 5 and unregulated F-actin, although
the eﬀect predominates at lower temperatures and is more
pronounced for regulated thin-ﬁlaments (Figure 5). Max-
imum velocity of sarcomere shortening [52, 70, 78, 79]
and unloaded sliding of unregulated F-actin [80]h a v e
previously been reported to increase with elevated Pi. This
is generally understood to be the result of reversal of cross-
bridge attachment, which decreases ts as demonstrated at the
single molecule level by Baker et al. [81], thus reducing the
number of strongly attached cross-bridges and increasing sm
(1). The relatively greater enhancement of sliding speed at
lower temperatures results in a generally shallow slope of
speed versus temperature for both regulated thin ﬁlaments
and unregulated F-actin (Figure 5) that corresponds to a
regime of relatively low Ea; in contrast to the result with
low ATP, the expectation is that elevated Pi should shift
Tt to a higher temperature (Figure 6). Taken together, the
data in Figure 5 illustrate that the relative importance of
factors which inﬂuence cross-bridge cycling kinetics and/or
ﬁlament sliding speed varies with temperature around the
physiologicalrange,andwhicharerate-limitingalsovariesas
implicated in Figure 6. This suggests that energetic state may
impact cardiac function when core body temperature varies,Journal of Biomedicine and Biotechnology 11
such as in mild hypothermia or with exercise, in ways that
may seem counterintuitive [31].
4.3. Implications for Understanding Cardiovascular Diseases.
Figure 4 illustrates that the microthermal heater can be
used to study eﬀects of disease-related mutations in human
cardiac Ca2+ regulatory proteins on function of individual
thin ﬁlaments. This clearly goes beyond, and will ultimately
help explain, prior work that examined physical properties
of the mutant proteins in bulk solution, and the Ca2+-
dependence of function. cTn mutations may inﬂuence not
just sm (TnI K206Q and TnT R278C), but also the temper-
ature dependence of Ea (TnI K206Q and TnT R278C) and
possibly Tt (TnI K206Q). The mutations may also inﬂuence
the temperature at which thin-ﬁlament structure is aﬀected
to the extent that dysregulation occurs and Ca2+ dependent
function is altered, whether the disease-related change in
function is most relevant in the myoﬁlaments, or perhaps
in the nucleus [82]. For all three Tn mutants examined
(TnI R145G, TnI K206Q, and TnT R278C) mutations
destabilized thin-ﬁlament structure and function at lower
temperatures than WT; this eﬀect was particularly noticeable
for an FHC mutant of human cardiac Tm (E180G) that
causes extreme shifts in Ca2+ sensitivity [33, 40]. Thus, we
anticipate that the thermoelectric heater will be generally
useful for characterization of clinically relevant mutants of
thin ﬁlament protein structural stability through assessment
of function at the level of individual thin ﬁlaments.
4.4. Conclusion. Results demonstrate the utility of our
thermoelectric controller for investigating molecular mecha-
nisms underlying biomolecular motor function, and cardio-
vascular diseases related to altered biomechanics of cardiac
myoﬁlament proteins. This assay provides a novel view
of structure-function relationships for cardiac thin ﬁla-
ments.
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